Jul 252016
 

By Talent4Boards Team

Talent4Boards – Great Talent builds Great Boards

– USA, MA – Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery and development of novel therapeutic candidates that engage the body’s ability to rebuild and repair its own cells and tissues, today announced the appointment of the experienced commercial executive, Thomas McCourt, to its Board of Directors, effective immediately.… => Read more

Acceleron Pharma appoints Tom McCourt to its Board of Directors

From:: Acceleron Pharma appoints Tom McCourt to its Board of Directors

 Posted by at 9:05 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: